KetamineÀ¸·Î Ä¡·áÇÑ ³Ä¡¼º °£Áú Áßø ȯÀÚ 2¿¹
Two Cases of Refractory Status Epilepticus Treated with Ketamine
ÀÌÁö¿¬, ¹Ú¼º¹Î, ±è¿µÀÎ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁö¿¬ ( Lee Ji-Youn )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¹Ú¼º¹Î ( Park Seong-Min )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±è¿µÀÎ ( Kim Yeong-In )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
KMID : 0877220010050010082
Abstract
Clinical observations and recent experimental studies have suggested that the longer status epilepticus (SE) persists, the more difficult it is to control SE pharmacologically. These findings imply that there are fundamental pathophysiologic processes, which make more resistant to intervene in the refractory SE. Recently, it has been recognized that ketamine, N-methyl-D-aspartate receptor antagonists, are effective agents in the treatment of the late stages of SE in the animal model. However, only one clinical experience has been reported. Here, we report two cases with refractory SE, responsive to ketamine.
Å°¿öµå
³Ä¡¼º °£Áú ÁßøÁõ; NMDA ¼ö¿ëü ±æÇ×Á¦(Ketamine)
Refractory status epilepticus; N-methyl-D-aspartate receptor antagonist; Ketamine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸